Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Net Margin Growth (3y) (2023 - 2026)

Sera Prognostics (SERA) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -641.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 459.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -108.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 941.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -1,024.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 574.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 216.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 647.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 300.00
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00 -2.13 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.80 Mn
Mar 31, 2026 -6.62 Mn
Dec 31, 2025 -3.56 Mn
Sep 30, 2025 -6.62 Mn
Jun 30, 2025 -5.76 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 974,744.00
Sep 30, 2024 1.44 Mn
Jun 30, 2024 37,167.00
Dec 31, 2023 6.92 Mn
Sep 30, 2023 8.27 Mn
Jun 30, 2023 6.89 Mn